These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8492514)

  • 1. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
    Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
    Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
    Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
    Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
    Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
    Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
    Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
    Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Qualitative analysis of the immunoreactive hCG beta-like substance produced by transitional cell carcinoma of the bladder].
    Yamanaka N; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1150-6. PubMed ID: 1716709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and secretion of the beta subunit of human chorionic gonadotropin by bladder carcinoma in vivo and in vitro.
    Nishimura R; Koizumi T; Morisue K; Yamanaka N; Lalwani R; Yoshimura M; Nakagawa T; Shii K; Hasegawa K; Baba S
    Cancer Res; 1995 Apr; 55(7):1479-84. PubMed ID: 7882356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
    Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
    Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ectopic production of HCG beta by bladder carcinoma in vitro and in vivo].
    Morisue K; Yamanaka N; Eto H; Kamidono S; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):643-9. PubMed ID: 8709440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of beta-human chorionic gonadotropin in urothelial carcinoma.
    Ozkardeş H; Ergen A; Ozen HA; Ayhan A; Remzi D
    Int Urol Nephrol; 1991; 23(1):5-11. PubMed ID: 1718919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of hCG β - related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-S32. PubMed ID: 29645231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary beta-HCG in benign and malignant urinary tract diseases.
    Halim AB; Barakat M; el-Zayat AM; Daw M; el-Ahmady O
    Dis Markers; 1995 Mar; 12(2):109-15. PubMed ID: 7542189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women.
    Lee CL; Iles RK; Shepherd JH; Hudson CN; Chard T
    J Endocrinol; 1991 Sep; 130(3):481-9. PubMed ID: 1719119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
    Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
    J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.